Bionano Genomics announced the conclusion of Bionano’s 2024 Symposium, the quintessential event for the optical genome mapping community, which was held January 22-25, 2024, and featured a record 32 oral presentations and 69 scientific posters from genomic scientists at leading institutions, including Brigham and Women’s Hospital, The University of Texas MD Anderson Cancer Center, Institute Curie, Memorial Sloan Kettering Cancer Center and Johns Hopkins University School of Medicine. Symposium had over 2,100 registrants from 92 countries and averaged 574 attendees per day. During this four-day online event, presenters reported on their use of OGM for applications in cancer, genetic disease, and cell and gene therapy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BNGO:
- Bionano Genomics announces publication of study on OGM
- Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing
- Bionano Genomics announces publication of second interim report of trial on OGM
- Bionano Genomics announces full commercial release of Stratys system
- Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications
